GSTM1 and colorectal cancer: This pooled analysis based on the individual data of 541 stage IV colorectal cancer patients treated with palliative chemotherapy confirms the prognostic value of previously identified factors such as CRP, Hb, and albumin and strengthens the existing data from other studies supporting the prognostic significance of DNA ploidy in stage IV colorectal cancer.